epocrates logo
epocrates logo
epocrates logo
  • 0

Drugs


Formulary
No Formulary Selected

Classes

  • All Drugs
  • Allergy/Cold/ENT
  • Anesthesia/Pain Management
  • Asthma/Pulmonary
  • Cardiovascular
  • Dental/Oral Care
  • Dermatologic
  • Diagnostic
  • Emergency
  • Endocrine/Metabolism
  • Gastrointestinal
  • Hematology/Oncology
  • Immunizations
  • Immunology
  • Infectious Disease
  • Nephrology/Urology
  • Neurologic
  • Nutrition/Electrolytes
  • Obstetrics/Gynecology
  • Ophthalmic
  • Psychiatric
  • Rheumatologic

Drug Names

# A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z
A+D Anti-Chafing Ointment
A+D Diaper Rash Cream
A+D First Aid Ointment
A+D Incontinence Support Skin Protectant & Rash Ointment
A+D Medicated Rash Ointment
A+D Original Ointment
A+D Overnight Healing Rash Ointment
abacavir
abacavir/dolutegravir/lamivudine
abacavir/lamivudine
abacavir/lamivudine/zidovudine
abaloparatide
abametapir topical
abatacept
Abecma
Abelcet
abemaciclib
Abigale
Abigale Lo
Abilify
Abilify Asimtufii
Abilify Discmelt
Abilify Maintena
Abilify MyCite
abiraterone acetate
abiraterone acetate micronized
Ablysinol
abobotulinumtoxinA
Abraxane
Abreva
Abreva Rapid Pain Relief
Abrilada (adalimumab-afzb)
abrocitinib
Abrysvo
Absorica
Absorica LD
Abstral
acalabrutinib
ACAM2000
acamprosate
Acanya
acarbose
Accolate
Accrufer
AccuNeb
Accupril
Accuretic
Accutane
acebutolol
aceclidine ophthalmic
Aceon
Acetadote
acetaminophen
acetaminophen rectal
acetaminophen/aspirin
acetaminophen/aspirin/caffeine
acetaminophen/aspirin/diphenhydramine
acetaminophen/caffeine
acetaminophen/caffeine/dihydrocodeine
acetaminophen/caffeine/pyrilamine
acetaminophen/chlorpheniramine
acetaminophen/chlorpheniramine/dextromethorphan
acetaminophen/chlorpheniramine/dextromethorphan/phenylephrine
acetaminophen/chlorpheniramine/dextromethorphan/pseudoephedrine
acetaminophen/chlorpheniramine/phenylephrine
acetaminophen/codeine
acetaminophen/dextromethorphan
acetaminophen/dextromethorphan/guaifenesin
acetaminophen/dextromethorphan/phenylephrine
acetaminophen/dextromethorphan/phenylephrine/guaifenesin
acetaminophen/dextromethorphan/pseudoephedrine
acetaminophen/diphenhydramine
acetaminophen/diphenhydramine/phenylephrine
acetaminophen/doxylamine/dextromethorphan
acetaminophen/doxylamine/dextromethorphan/phenylephrine
acetaminophen/guaifenesin
acetaminophen/ibuprofen
acetaminophen/pamabrom
acetaminophen/pamabrom/pyrilamine
acetaminophen/phenylephrine
acetaminophen/phenylephrine/guaifenesin
acetaminophen/pseudoephedrine
acetaminophen/triprolidine/dextromethorphan
acetaminophen/triprolidine/dextromethorphan/phenylephrine
acetazolamide
acetic acid otic
acetohydroxamic acid
acetylcholine intraocular
acetylcysteine
Aciphex
Aciphex Sprinkle
acitretin
aclidinium bromide inhaled
aclidinium bromide/formoterol inhaled
Aclovate
acoltremon ophthalmic
acoramidis
acrivastine/pseudoephedrine
Actemra
Acthar Gel
ActHIB
Acticlate
Actidose with Sorbitol
Actidose-Aqua
Actigall
Actimmune
Actiq
Activase
Activella
Actonel
Actonel with Calcium
ACTOplus met
ACTOplus met XR
Actos
Acular
Acular LS
Acuvail
Acuvue Theravision with Ketotifen
acyclovir
acyclovir oropharyngeal
acyclovir topical
acyclovir/hydrocortisone topical
Aczone
Adacel
adagrasib
Adakveo (crizanlizumab-tmca)
Adalat CC
adalimumab
ADAMTS13, recombinant
adapalene topical
adapalene/benzoyl peroxide topical
Adasuve
Adbry (tralokinumab-ldrm)
Adcetris
Adcirca
Adderall
Adderall XR
Addyi
adefovir dipivoxil
Adempas
Adenocard
Adenoscan
adenosine
adenovirus type 4 and type 7 vaccine, live oral
Adhansia XR
Adipex-P
Adlarity
Adlyxin
Admelog
ado-trastuzumab emtansine
Adoxa
Adquey
Adrenaclick
Adrenalin
Adriamycin
Adrucil
Adstiladrin (nadofaragene firadenovec-vncg)
aducanumab
Aduhelm (aducanumab-avwa)
Advair Diskus
Advair HFA
Advate
Advil
Advil Allergy & Congestion Relief
Advil Allergy Sinus
Advil Cold & Sinus
Advil Dual Action with Acetaminophen
Advil Dual Action with Acetaminophen Back Pain
Advil Migraine
Advil Multi-Symptom Cold & Flu
Advil PM
Advil Sinus Congestion & Pain
Advil Targeted Relief Cream
Adynovate
Adzenys ER
Adzenys XR-ODT
Adzynma (ADAMTS13, recombinant-krhn)
Aemcolo
afamelanotide
afamitresgene autoleucel
afatinib
Afeditab CR
aficamten
Afinitor
Afinitor Disperz
aflibercept intravitreal
Afluria
Afrezza
Afrin Allergy Sinus
Afrin No Drip Allergy Sinus
Afrin No Drip Allergy Sinus Night
Afrin No Drip Extra Moisturizing
Afrin No Drip Night
Afrin No Drip Original
Afrin No Drip Severe Congestion
Afrin Original
Afrin Severe Congestion
Afstyla
agalsidase beta
Agamree
Aggrastat
Aggrenox
Agrylin
Ahzantive (aflibercept-mrbb)
Aimovig (erenumab-aooe)
air polymer-type A
AirDuo Digihaler
AirDuo RespiClick
Airsupra
Ajovy (fremanezumab-vfrm)
AK-Dilate
AK-Poly-Bac
Akeega
Aklief
Akne-mycin
Akovaz
Akten
Aktipak
Akynzeo
Akynzeo IV
Ala-hist IR
Alahist CF
Alahist D
Alahist DM
Alahist PE
Alamast
Alavert
Alavert D-12 Hour
Alaway
albendazole
Albenza
albiglutide
Albuked
albumin (human)
Albuminar
Albuminex (albumin (human)-kjda)
AlbuRx
Albutein
albuterol
albuterol inhaled
albuterol/budesonide inhaled
alcaftadine ophthalmic
Alcaine
alclometasone topical
Aldactazide
Aldactone
Aldara
aldesleukin
Aldomet
Aldurazyme
Alecensa
alectinib
alemtuzumab
alendronate
alendronate/cholecalciferol
Alesse
Aleve
Aleve Arthritis Pain Gel
Aleve Back & Muscle Pain
Aleve Headache Pain
Aleve PM
Aleve-D Sinus & Cold
AleveX Lotion
AleveX Spray
Alfenta
alfentanil
alfuzosin
alglucosidase alfa
Alhemo (concizumab-mtci)
Alimta
Alinia
Aliqopa
alirocumab
aliskiren
aliskiren/hydrochlorothiazide
alitretinoin topical
Alka-Seltzer Cool Action Heartburn Relief Gum
Alka-Seltzer Extra Strength Heartburn ReliefChews
Alka-Seltzer Extra Strength Upset Stomach Relief
Alka-Seltzer Hangover Relief
Alka-Seltzer Heartburn + Gas ReliefChews
Alka-Seltzer Original
Alka-Seltzer Plus Cold & Flu FizzyChews
Alka-Seltzer Plus Cough & Sore Throat FizzyChews
Alka-Seltzer Plus Maximum Strength Cold & Cough
Alka-Seltzer Plus Maximum Strength Cold & Cough PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Day
Alka-Seltzer Plus Maximum Strength Cold & Flu Day PowerMax
Alka-Seltzer Plus Maximum Strength Cold & Flu Night
Alka-Seltzer Plus Maximum Strength Cold & Flu Night PowerMax
Alka-Seltzer Plus Maximum Strength Cough & Chest Congestion Power...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Cough, Mucus & Congestion Powe...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerF...
Alka-Seltzer Plus Maximum Strength Sinus Congestion & Pain PowerM...
Alka-Seltzer Plus Maximum Strength Sinus, Allergy & Cough PowerMa...
Alka-Seltzer Plus Severe Cold & Cough PowerFast Fizz
Alka-Seltzer Plus Severe Cold & Flu Day
Alka-Seltzer Plus Severe Cold & Flu Night
Alka-Seltzer Plus Severe Cold & Flu PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz
Alka-Seltzer Plus Severe Cold PowerFast Fizz Night
Alka-Seltzer Plus Severe Cold PowerFast Fizz Non-Drowsy
Alka-Seltzer Plus Severe Sinus, Cold & Cough
Alka-Seltzer Upset Stomach Relief
Alkeran
Alkindi Sprinkle
Allegra Allergy 12 Hour
Allegra Allergy 24 Hour
Allegra Hives 24 Hour
Allegra-D 12 Hour Allergy & Congestion
Allegra-D 24 Hour Allergy & Congestion
Aller-chlor
Alli
allogeneic cell therapy
allopurinol
Allzital
almotriptan
Alocril
alogliptin
alogliptin/metformin
alogliptin/pioglitazone
Alomide
Aloprim
Alora
alosetron
Aloxi
alpelisib
alpha-tocopherol (vitamin E)
alpha1-proteinase inhibitor
Alphagan P
Alphanate
alprazolam
Alprolix
alprostadil
alprostadil intracavernous
alprostadil intraurethral
Alrex
Alsuma
Altabax
Altace
Altafluor Benox
Altavera
alteplase
alteplase intracatheter
Altoprev
Altreno
Altuviiio (antihemophilic factor (recombinant), Fc-VWF-XTEN fusio...
aluminum acetate topical (modified Burow's solution)
aluminum chloride topical
aluminum hydroxide
aluminum hydroxide/magnesium carbonate
aluminum hydroxide/magnesium hydroxide
aluminum hydroxide/magnesium hydroxide/simethicone
Alunbrig
Alvaiz
Alvesco
alvimopan
Alyacen 1/35
Alyacen 7/7/7
Alyftrek
Alyglo (immune globulin human-stwk)
Alymsys (bevacizumab-maly)
Alyq
Amabelz
amantadine
Amaryl
Ambien
Ambien CR
AmBisome
ambrisentan
amcinonide topical
Ameluz
Amerge
Amethia
Amethia Lo
Amethyst
Amicar
Amidate
amifampridine
amifostine
amikacin
amikacin liposomal inhaled
Amikin
amiloride
amiloride/hydrochlorothiazide
aminocaproic acid
aminolevulinic acid topical
aminophylline
amiodarone
amisulpride
Amitiza
amitriptyline
amivantamab
amivantamab/hyaluronidase
Amjevita (adalimumab-atto)
amlodipine
amlodipine/atorvastatin
amlodipine/benazepril
amlodipine/celecoxib
amlodipine/olmesartan medoxomil
amlodipine/valsartan
amlodipine/valsartan/hydrochlorothiazide
ammonium lactate topical
Ammonul
Amnesteem
Amondys 45
amoxapine
amoxicillin
amoxicillin/clavulanate
Amoxil
Amphadase
amphetamine
Amphocin
Amphojel
Amphotec
amphotericin B cholesteryl sulfate
amphotericin B deoxycholate
amphotericin B lipid complex
amphotericin B liposomal
ampicillin
ampicillin/sulbactam
Ampyra
Amrix
Amtagvi
Amvuttra
amyl nitrite/sodium nitrite/sodium thiosulfate
Amzeeq
anacaulase topical
Anacin
Anafranil
anagrelide
anakinra
Analpram E
Analpram HC
AnaMantle HC
Anaphylm
Anaprox
Anaprox DS
Anascorp
Anaspaz
anastrozole
Anavip
Anbesol Maximum Strength
Ancef
Ancobon
Andembry (garadacimab-gxii)
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
Androderm
AndroGel
Android
Androxy
Anectine
Angeliq
Angiomax
Angiomax RTU
angiotensin II
anidulafungin
anifrolumab
Anjeso
Anktiva (nogapendekin alfa inbakicept-pmln)
Annovera
Anoro Ellipta
Ansaid
ansuvimab
Antabuse
Antara
Anthim
Anthrasil
anthrax immune globulin (human)
anthrax vaccine
anthrax vaccine, adjuvanted
anti-inhibitor coagulant complex
anti-thymocyte globulin (rabbit)
antihemophilic factor (factor VIII, human)
antihemophilic factor (factor VIII, human)/von Willebrand factor ...
antihemophilic factor (factor VIII, recombinant)
antihemophilic factor (factor VIII, recombinant), Fc fusion prote...
antihemophilic factor (factor VIII, recombinant), glycopegylated
antihemophilic factor (factor VIII, recombinant), pegylated
antihemophilic factor (factor VIII, recombinant), porcine
antihemophilic factor (factor VIII, recombinant), single chain
antihemophilic factor (recombinant), Fc-VWF-XTEN fusion protein
antipyrine/benzocaine otic
antithrombin (recombinant)
antithrombin III
Antivert
Antizol
Anucort-HC
Anusol-HC Cream
Anusol-HC Suppository
Anzupgo
Apadaz
apalutamide
ApexiCon
ApexiCon E
Aphexda
Apidra
apitegromab
Apitegromab
apixaban
Aplenzin
Aplisol
Apokyn
apomorphine
Aponvie
apraclonidine ophthalmic
apremilast
aprepitant
Apresoline
Apretude
Apri
Apriso
aprocitentan
Aptensio XR
Aptiom
Aptivus
Aqneursa
Aquaphor
Aquaphor Baby Diaper Rash
Aquaphor Itch Relief
Aquasol A
Aquasol E
Aqvesme
Arakoda
Aralast NP
Aralen
Aranelle
Aranesp
Arava
Arazlo
Arbinoxa
Arbli
Arcalyst
Aredia
Arepanrix
Arexvy
arformoterol inhaled
argatroban
arginine
Aricept
Aricept ODT
Arikayce
Arimidex
arimoclomol
aripiprazole
aripiprazole bimonthly injection
aripiprazole lauroxil
aripiprazole monthly injection
Aristada
Aristada Initio
Arixtra
Armlupeg (pegfilgrastim-unne)
armodafinil
ArmonAir Digihaler
ArmonAir RespiClick
Armour Thyroid
Arnuity Ellipta
Aromasin
Arranon
arsenic trioxide
Artane
artemether/lumefantrine
artesunate
Arthriten
Arthritis Hot
Arthrotec
articaine/epinephrine
Arymo ER
Arynta
Arzerra
Asacol
Asacol HD
Asceniv (immune globulin human-slra)
asciminib
Ascor
ascorbic acid (vitamin C)
asenapine
asenapine transdermal
asfotase alfa
Ashlyna
Asmanex HFA
Asmanex Twisthaler
asparaginase
asparaginase Erwinia chrysanthemi
asparaginase erwinia chrysanthemi (recombinant)
Asparlas (calaspargase pegol-mknl)
Aspercreme
Aspercreme Arthritis Pain
Aspercreme Lidocaine 3 in 1 Foot Pain Relief Cream
Aspercreme Lidocaine Foot Pain Cream for Diabetic Skin
Aspercreme Lidocaine Pain Relief Cream
Aspercreme Lidocaine Pain Relief Liquid Roll-On
Aspercreme Lidocaine Pain Relief Patch
Aspercreme Lidocaine Pain Relief Spray
aspirin
aspirin/caffeine
aspirin/chlorpheniramine/dextromethorphan/phenylephrine
aspirin/chlorpheniramine/phenylephrine
aspirin/dextromethorphan/phenylephrine
aspirin/dipyridamole
aspirin/omeprazole
Aspruzyo Sprinkle
Astagraf XL
Astelin
Astepro Allergy
Asthmanefrin
Atacand
Atacand HCT
atacicept
Atacicept
Atarax
atazanavir
atazanavir/cobicistat
Atelvia
atenolol
atenolol/chlorthalidone
atezolizumab
atezolizumab/hyaluronidase
Atgam
atidarsagene autotemcel
Ativan
Atmeksi
atogepant
atoltivimab/maftivimab/odesivimab
atomoxetine
Atorvaliq
atorvastatin
atovaquone
atovaquone/proguanil
atracurium
Atralin
atrasentan
Atripla
AtroPen
atropine
atropine ophthalmic
atropine/pralidoxime
Atrovent HFA
Atrovent Nasal
ATryn
Attruby
Atzumi
Aubagio
Aubra EQ
Aucatzyl
Audenz
Augmentin
Augmentin ES-600
Augmentin XR
Augtyro
Aukelso (denosumab-kyqq)
Auralgan (original formulation)
auranofin
Aurlumyn
Aurovela 1.5/30
Aurovela 1/20
Aurovela 24 Fe
Aurovela Fe 1.5/30
Aurovela Fe 1/20
Auryxia
Austedo
Austedo XR
autologous mesenchymal stem cell-neurotrophic factor (MSC-NTF) ce...
Auvelity
Auvi-Q
avacincaptad pegol intravitreal
avacopan
Avage
avalglucosidase alfa
Avalide
avanafil
Avandaryl
Avandia
avapritinib
Avapro
Avasopasem
avasopasem
Avastin
avatrombopag
Aveed
Aveeno Anti-Itch Concentrated Lotion
Aveeno Baby Calming Comfort Lotion
Aveeno Baby Daily Moisture Cream
Aveeno Baby Daily Moisture Lotion
Aveeno Baby Eczema Therapy Moisturizing Cream
Aveeno Baby Eczema Therapy Nighttime Balm
Aveeno Baby Eczema Therapy Soothing Bath Treatment
Aveeno Calm + Restore Skin Therapy Balm
Aveeno Daily Moisturizing Lotion
Aveeno Eczema Therapy Moisturizing Cream
Aveeno Eczema Therapy Nighttime Itch Relief Balm
Aveeno Eczema Therapy Rescue Relief Treatment Gel Cream
Aveeno Hydrocortisone Anti-Itch Cream
Aveeno Positively Radiant Clear Complexion
Aveeno Skin Relief Hand Cream
Aveeno Skin Relief Moisturizing Lotion
Aveeno Skin Relief Overnight Cream
Aveeno Soothing Bath Treatment
Avelox
avelumab
Averi
Avgemsi
Aviane
Avidoxy
Avinza
Avita
Avlayah (tividenofusp alfa-eknm)
Avmapki Fakzynja Co-Pack
Avodart
Avonex
Avopef
Avsola (infliximab-axxq)
Avtozma (tocilizumab-anoh)
avutometinib and defactinib
Avycaz
Avzivi (bevacizumab-tnjn)
axatilimab
Axert
axicabtagene ciloleucel
Axid
Axiron
axitinib
Axtle
Aygestin
Ayvakit
azacitidine
Azactam
Azasan
AzaSite
azathioprine
Azedra
azelaic acid topical
azelastine nasal
azelastine ophthalmic
azelastine/fluticasone propionate nasal
Azelex
Azilect
azilsartan medoxomil
azilsartan medoxomil/chlorthalidone
azithromycin
azithromycin ophthalmic
Azmacort
Azmiro
Azo Urinary Pain Relief
Azo Urinary Pain Relief Maximum Strength
Azopt
Azor
Azstarys
aztreonam
aztreonam inhaled
aztreonam/avibactam
Azulfidine
Azulfidine EN-tabs
Azurette

close

 

Select a medication above to begin.

Nurtec ODT

rimegepant

Drug Monograph

  • Black Box Warnings
  • Adult Dosing
  • Peds Dosing
  • Contraindications/Cautions
  • Drug Interactions
  • Adverse Reactions
  • Safety/Monitoring
  • Pregnancy/Lactation
  • Pharmacology
  • Formulary
  • Manufacturer/Pricing
  • Patient Education
  • Pill Pictures
  • Add to Interaction Check
  • Dosing Calculator

Adult Dosing .

Dosage forms:  ODT: 75 mg

migraine, acute

[75 mg PO/SL x1]
Max: 75 mg/24h

migraine prophylaxis, episodic

[75 mg PO/SL qod]

renal dosing

[see below]
CrCl >15: no adjustment; CrCl <15: not defined
HD/PD: not defined

hepatic dosing

[see below]
Child-Pugh Class C: avoid use

Peds Dosing .

Peds dosing is currently unavailable or not applicable for this drug.

Contraindications / Cautions .

    com.epocrates.rxweb.beans.StringCollection@74af21ff
  • hypersensitivity to drug or ingredient
  • hepatic impairment, Child-Pugh Class C
  • caution: HTN
  • caution: Raynaud phenomenon

Drug Interactions .

Overview

rimegepant

CGRP antagonist

Interaction Characteristics:
  • CYP3A4 substrate
  • P-gp substrate
  • hypertensive effects

Avoid/Use Alternative

  • adagrasib
  • Nurtec ODT (rimegepant)
    +
    adagrasib
    1 interaction

    Avoid/Use Alternative

    rimegepant + adagrasib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • apalutamide
  • Nurtec ODT (rimegepant)
    +
    apalutamide
    1 interaction

    Avoid/Use Alternative

    rimegepant + apalutamide

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • atazanavir
  • Nurtec ODT (rimegepant)
    +
    atazanavir
    1 interaction

    Avoid/Use Alternative

    rimegepant + atazanavir

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • atogepant
  • Nurtec ODT (rimegepant)
    +
    atogepant
    1 interaction

    Avoid/Use Alternative

    rimegepant + atogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • bosentan
  • Nurtec ODT (rimegepant)
    +
    bosentan
    1 interaction

    Avoid/Use Alternative

    rimegepant + bosentan

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • butalbital
  • Nurtec ODT (rimegepant)
    +
    butalbital
    1 interaction

    Avoid/Use Alternative

    rimegepant + butalbital

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • carbamazepine
  • Nurtec ODT (rimegepant)
    +
    carbamazepine
    1 interaction

    Avoid/Use Alternative

    rimegepant + carbamazepine

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • cenobamate
  • Nurtec ODT (rimegepant)
    +
    cenobamate
    1 interaction

    Avoid/Use Alternative

    rimegepant + cenobamate

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • ceritinib
  • Nurtec ODT (rimegepant)
    +
    ceritinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + ceritinib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • chloramphenicol
  • Nurtec ODT (rimegepant)
    +
    chloramphenicol
    1 interaction

    Avoid/Use Alternative

    rimegepant + chloramphenicol

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • clarithromycin
  • Nurtec ODT (rimegepant)
    +
    clarithromycin
    1 interaction

    Avoid/Use Alternative

    rimegepant + clarithromycin

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • cobicistat
  • Nurtec ODT (rimegepant)
    +
    cobicistat
    1 interaction

    Avoid/Use Alternative

    rimegepant + cobicistat

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • dabrafenib
  • Nurtec ODT (rimegepant)
    +
    dabrafenib
    1 interaction

    Avoid/Use Alternative

    rimegepant + dabrafenib

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • efavirenz
  • Nurtec ODT (rimegepant)
    +
    efavirenz
    1 interaction

    Avoid/Use Alternative

    rimegepant + efavirenz

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • encorafenib
  • Nurtec ODT (rimegepant)
    +
    encorafenib
    1 interaction

    Avoid/Use Alternative

    rimegepant + encorafenib

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • enzalutamide
  • Nurtec ODT (rimegepant)
    +
    enzalutamide
    1 interaction

    Avoid/Use Alternative

    rimegepant + enzalutamide

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • epinephrine inhaled
  • Nurtec ODT (rimegepant)
    +
    epinephrine inhaled
    1 interaction

    Avoid/Use Alternative

    rimegepant + epinephrine inhaled

    avoid combo: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • eptinezumab
  • Nurtec ODT (rimegepant)
    +
    eptinezumab
    1 interaction

    Avoid/Use Alternative

    rimegepant + eptinezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • erenumab
  • Nurtec ODT (rimegepant)
    +
    erenumab
    1 interaction

    Avoid/Use Alternative

    rimegepant + erenumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • etravirine
  • Nurtec ODT (rimegepant)
    +
    etravirine
    1 interaction

    Avoid/Use Alternative

    rimegepant + etravirine

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • fexinidazole
  • Nurtec ODT (rimegepant)
    +
    fexinidazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + fexinidazole

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • fosphenytoin
  • Nurtec ODT (rimegepant)
    +
    fosphenytoin
    1 interaction

    Avoid/Use Alternative

    rimegepant + fosphenytoin

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • fremanezumab
  • Nurtec ODT (rimegepant)
    +
    fremanezumab
    1 interaction

    Avoid/Use Alternative

    rimegepant + fremanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • furosemide
  • Nurtec ODT (rimegepant)
    +
    furosemide
    1 interaction

    Avoid/Use Alternative

    rimegepant + furosemide

    use alternative or monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • galcanezumab
  • Nurtec ODT (rimegepant)
    +
    galcanezumab
    1 interaction

    Avoid/Use Alternative

    rimegepant + galcanezumab

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • idelalisib
  • Nurtec ODT (rimegepant)
    +
    idelalisib
    1 interaction

    Avoid/Use Alternative

    rimegepant + idelalisib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • itraconazole
  • Nurtec ODT (rimegepant)
    +
    itraconazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + itraconazole

    avoid combo during and x2wk after itraconazole tx: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • ivosidenib
  • Nurtec ODT (rimegepant)
    +
    ivosidenib
    1 interaction

    Avoid/Use Alternative

    rimegepant + ivosidenib

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • ketoconazole
  • Nurtec ODT (rimegepant)
    +
    ketoconazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + ketoconazole

    avoid combo during and up to 1wk after ketoconazole tx: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • levoketoconazole
  • Nurtec ODT (rimegepant)
    +
    levoketoconazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + levoketoconazole

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • lonafarnib
  • Nurtec ODT (rimegepant)
    +
    lonafarnib
    1 interaction

    Avoid/Use Alternative

    rimegepant + lonafarnib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • lopinavir/ritonavir
  • Nurtec ODT (rimegepant)
    +
    lopinavir/ ritonavir
    1 interaction

    Avoid/Use Alternative

    rimegepant + lopinavir/ ritonavir

    avoid combo: combo may incr. or decr. rimegepant levels, incr. risk of adverse effects or decr. efficacy (hepatic metabolism altered, P-gp-mediated transport inhibited)

  • lorlatinib
  • Nurtec ODT (rimegepant)
    +
    lorlatinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + lorlatinib

    avoid combo: combo may decr. rimegepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • lumacaftor/ivacaftor
  • Nurtec ODT (rimegepant)
    +
    lumacaftor/ ivacaftor
    1 interaction

    Avoid/Use Alternative

    rimegepant + lumacaftor/ ivacaftor

    avoid combo: combo may decr. rimegepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • mavacamten
  • Nurtec ODT (rimegepant)
    +
    mavacamten
    1 interaction

    Avoid/Use Alternative

    rimegepant + mavacamten

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • midodrine
  • Nurtec ODT (rimegepant)
    +
    midodrine
    1 interaction

    Avoid/Use Alternative

    rimegepant + midodrine

    use alternative or monitor BP: combo may incr. risk of HTN (additive effects)

  • mifepristone
  • Nurtec ODT (rimegepant)
    +
    mifepristone
    1 interaction

    Avoid/Use Alternative

    rimegepant + mifepristone

    avoid combo during and x14 days after daily mifepristone use: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • mitapivat
  • Nurtec ODT (rimegepant)
    +
    mitapivat
    1 interaction

    Avoid/Use Alternative

    rimegepant + mitapivat

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • mitotane
  • Nurtec ODT (rimegepant)
    +
    mitotane
    1 interaction

    Avoid/Use Alternative

    rimegepant + mitotane

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • modafinil
  • Nurtec ODT (rimegepant)
    +
    modafinil
    1 interaction

    Avoid/Use Alternative

    rimegepant + modafinil

    avoid combo: combo may decr. rimegepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • nafcillin
  • Nurtec ODT (rimegepant)
    +
    nafcillin
    1 interaction

    Avoid/Use Alternative

    rimegepant + nafcillin

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • nefazodone
  • Nurtec ODT (rimegepant)
    +
    nefazodone
    1 interaction

    Avoid/Use Alternative

    rimegepant + nefazodone

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • nelfinavir
  • Nurtec ODT (rimegepant)
    +
    nelfinavir
    1 interaction

    Avoid/Use Alternative

    rimegepant + nelfinavir

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • netupitant
  • Nurtec ODT (rimegepant)
    +
    netupitant
    1 interaction

    Avoid/Use Alternative

    rimegepant + netupitant

    use alternative or consider separating rimegepant doses by at least 48h during and x1wk after (fos)netupitant tx: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • pacritinib
  • Nurtec ODT (rimegepant)
    +
    pacritinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + pacritinib

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • pentobarbital
  • Nurtec ODT (rimegepant)
    +
    pentobarbital
    1 interaction

    Avoid/Use Alternative

    rimegepant + pentobarbital

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • pexidartinib
  • Nurtec ODT (rimegepant)
    +
    pexidartinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + pexidartinib

    avoid combo: combo may decr. rimegepant levels, efficacy; may incr. risk of HTN (hepatic metabolism induced; additive effects)

  • phenobarbital
  • Nurtec ODT (rimegepant)
    +
    phenobarbital
    1 interaction

    Avoid/Use Alternative

    rimegepant + phenobarbital

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • phenytoin
  • Nurtec ODT (rimegepant)
    +
    phenytoin
    1 interaction

    Avoid/Use Alternative

    rimegepant + phenytoin

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • posaconazole
  • Nurtec ODT (rimegepant)
    +
    posaconazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + posaconazole

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • primidone
  • Nurtec ODT (rimegepant)
    +
    primidone
    1 interaction

    Avoid/Use Alternative

    rimegepant + primidone

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • repotrectinib
  • Nurtec ODT (rimegepant)
    +
    repotrectinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + repotrectinib

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • ribociclib
  • Nurtec ODT (rimegepant)
    +
    ribociclib
    1 interaction

    Avoid/Use Alternative

    rimegepant + ribociclib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • rifabutin
  • Nurtec ODT (rimegepant)
    +
    rifabutin
    1 interaction

    Avoid/Use Alternative

    rimegepant + rifabutin

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • rifampin
  • Nurtec ODT (rimegepant)
    +
    rifampin
    1 interaction

    Avoid/Use Alternative

    rimegepant + rifampin

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • rifapentine
  • Nurtec ODT (rimegepant)
    +
    rifapentine
    1 interaction

    Avoid/Use Alternative

    rimegepant + rifapentine

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • rimegepant
  • Nurtec ODT (rimegepant)
    +
    rimegepant
    1 interaction

    Avoid/Use Alternative

    rimegepant + rimegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • ritonavir
  • Nurtec ODT (rimegepant)
    +
    ritonavir
    1 interaction

    Avoid/Use Alternative

    rimegepant + ritonavir

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • sotorasib
  • Nurtec ODT (rimegepant)
    +
    sotorasib
    1 interaction

    Avoid/Use Alternative

    rimegepant + sotorasib

    avoid combo: combo may incr. or decr. rimegepant levels, incr. risk of adverse effects or decr. efficacy (P-gp-mediated transport inhibited; hepatic metabolism induced)

  • St. John's wort
  • Nurtec ODT (rimegepant)
    +
    St. John's wort
    1 interaction

    Avoid/Use Alternative

    rimegepant + St. John's wort

    avoid combo: combo may decr. rimegepant levels, efficacy (hepatic metabolism induced)

  • tipranavir
  • Nurtec ODT (rimegepant)
    +
    tipranavir
    1 interaction

    Avoid/Use Alternative

    rimegepant + tipranavir

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • tucatinib
  • Nurtec ODT (rimegepant)
    +
    tucatinib
    1 interaction

    Avoid/Use Alternative

    rimegepant + tucatinib

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • ubrogepant
  • Nurtec ODT (rimegepant)
    +
    ubrogepant
    1 interaction

    Avoid/Use Alternative

    rimegepant + ubrogepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

  • voriconazole
  • Nurtec ODT (rimegepant)
    +
    voriconazole
    1 interaction

    Avoid/Use Alternative

    rimegepant + voriconazole

    avoid combo: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • zavegepant
  • Nurtec ODT (rimegepant)
    +
    zavegepant
    1 interaction

    Avoid/Use Alternative

    rimegepant + zavegepant

    avoid combo: combo may incr. risk of HTN, other adverse effects (additive effects, duplicate therapy)

Monitor/Modify Tx

  • abiraterone acetate
  • Nurtec ODT (rimegepant)
    +
    abiraterone acetate
    1 interaction

    Monitor/Modify Tx

    rimegepant + abiraterone acetate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • acebutolol
  • Nurtec ODT (rimegepant)
    +
    acebutolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + acebutolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • albuterol
  • Nurtec ODT (rimegepant)
    +
    albuterol
    1 interaction

    Monitor/Modify Tx

    rimegepant + albuterol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • albuterol inhaled
  • Nurtec ODT (rimegepant)
    +
    albuterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + albuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aliskiren
  • Nurtec ODT (rimegepant)
    +
    aliskiren
    1 interaction

    Monitor/Modify Tx

    rimegepant + aliskiren

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • almotriptan
  • Nurtec ODT (rimegepant)
    +
    almotriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + almotriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • amiloride
  • Nurtec ODT (rimegepant)
    +
    amiloride
    1 interaction

    Monitor/Modify Tx

    rimegepant + amiloride

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amiodarone
  • Nurtec ODT (rimegepant)
    +
    amiodarone
    1 interaction

    Monitor/Modify Tx

    rimegepant + amiodarone

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • amlodipine
  • Nurtec ODT (rimegepant)
    +
    amlodipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + amlodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • amphetamine
  • Nurtec ODT (rimegepant)
    +
    amphetamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + amphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • angiotensin II
  • Nurtec ODT (rimegepant)
    +
    angiotensin II
    1 interaction

    Monitor/Modify Tx

    rimegepant + angiotensin II

    monitor BP: combo may incr. risk of HTN (additive effects)

  • aprepitant
  • Nurtec ODT (rimegepant)
    +
    aprepitant
    1 interaction

    Monitor/Modify Tx

    rimegepant + aprepitant

    if aprepitant 3-day regimen, separate rimegepant doses by at least 48h; aprepitant single dose-regimen OK: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • aprocitentan
  • Nurtec ODT (rimegepant)
    +
    aprocitentan
    1 interaction

    Monitor/Modify Tx

    rimegepant + aprocitentan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • arformoterol inhaled
  • Nurtec ODT (rimegepant)
    +
    arformoterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + arformoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • armodafinil
  • Nurtec ODT (rimegepant)
    +
    armodafinil
    1 interaction

    Monitor/Modify Tx

    rimegepant + armodafinil

    monitor BP: combo may incr. risk of HTN (additive effects)

  • asciminib
  • Nurtec ODT (rimegepant)
    +
    asciminib
    1 interaction

    Monitor/Modify Tx

    rimegepant + asciminib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atenolol
  • Nurtec ODT (rimegepant)
    +
    atenolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + atenolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • atomoxetine
  • Nurtec ODT (rimegepant)
    +
    atomoxetine
    1 interaction

    Monitor/Modify Tx

    rimegepant + atomoxetine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • atropine ophthalmic
  • Nurtec ODT (rimegepant)
    +
    atropine ophthalmic
    1 interaction

    Monitor/Modify Tx

    rimegepant + atropine ophthalmic

    monitor BP: combo may incr. risk of HTN (additive effects)

  • avacopan
  • Nurtec ODT (rimegepant)
    +
    avacopan
    1 interaction

    Monitor/Modify Tx

    rimegepant + avacopan

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • axitinib
  • Nurtec ODT (rimegepant)
    +
    axitinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + axitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • azilsartan medoxomil
  • Nurtec ODT (rimegepant)
    +
    azilsartan medoxomil
    1 interaction

    Monitor/Modify Tx

    rimegepant + azilsartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • azithromycin
  • Nurtec ODT (rimegepant)
    +
    azithromycin
    1 interaction

    Monitor/Modify Tx

    rimegepant + azithromycin

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • belumosudil
  • Nurtec ODT (rimegepant)
    +
    belumosudil
    1 interaction

    Monitor/Modify Tx

    rimegepant + belumosudil

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • benazepril
  • Nurtec ODT (rimegepant)
    +
    benazepril
    1 interaction

    Monitor/Modify Tx

    rimegepant + benazepril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • benzphetamine
  • Nurtec ODT (rimegepant)
    +
    benzphetamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + benzphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • berotralstat
  • Nurtec ODT (rimegepant)
    +
    berotralstat
    1 interaction

    Monitor/Modify Tx

    rimegepant + berotralstat

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • betamethasone
  • Nurtec ODT (rimegepant)
    +
    betamethasone
    1 interaction

    Monitor/Modify Tx

    rimegepant + betamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • betaxolol
  • Nurtec ODT (rimegepant)
    +
    betaxolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + betaxolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bevacizumab
  • Nurtec ODT (rimegepant)
    +
    bevacizumab
    1 interaction

    Monitor/Modify Tx

    rimegepant + bevacizumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bismuth subsalicylate
  • Nurtec ODT (rimegepant)
    +
    bismuth subsalicylate
    1 interaction

    Monitor/Modify Tx

    rimegepant + bismuth subsalicylate

    monitor BP w/ high-dose bismuth subsalicylate: combo may incr. risk of HTN (additive effects)

  • bisoprolol
  • Nurtec ODT (rimegepant)
    +
    bisoprolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + bisoprolol

    monitor BP; consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • brigatinib
  • Nurtec ODT (rimegepant)
    +
    brigatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + brigatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • budesonide
  • Nurtec ODT (rimegepant)
    +
    budesonide
    1 interaction

    Monitor/Modify Tx

    rimegepant + budesonide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • bumetanide
  • Nurtec ODT (rimegepant)
    +
    bumetanide
    1 interaction

    Monitor/Modify Tx

    rimegepant + bumetanide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • bupropion
  • Nurtec ODT (rimegepant)
    +
    bupropion
    1 interaction

    Monitor/Modify Tx

    rimegepant + bupropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cabozantinib
  • Nurtec ODT (rimegepant)
    +
    cabozantinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + cabozantinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • caffeine
  • Nurtec ODT (rimegepant)
    +
    caffeine
    1 interaction

    Monitor/Modify Tx

    rimegepant + caffeine

    monitor BP; avoid excessive caffeine intake: combo may incr. risk of HTN (additive effects)

  • caffeine citrate
  • Nurtec ODT (rimegepant)
    +
    caffeine citrate
    1 interaction

    Monitor/Modify Tx

    rimegepant + caffeine citrate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • candesartan cilexetil
  • Nurtec ODT (rimegepant)
    +
    candesartan cilexetil
    1 interaction

    Monitor/Modify Tx

    rimegepant + candesartan cilexetil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cannabidiol
  • Nurtec ODT (rimegepant)
    +
    cannabidiol
    1 interaction

    Monitor/Modify Tx

    rimegepant + cannabidiol

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (gut P-gp-mediated transport inhibited)

  • cannabis
  • Nurtec ODT (rimegepant)
    +
    cannabis
    1 interaction

    Monitor/Modify Tx

    rimegepant + cannabis

    monitor BP: combo may incr. risk of HTN (additive effects)

  • captopril
  • Nurtec ODT (rimegepant)
    +
    captopril
    1 interaction

    Monitor/Modify Tx

    rimegepant + captopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • carfilzomib
  • Nurtec ODT (rimegepant)
    +
    carfilzomib
    1 interaction

    Monitor/Modify Tx

    rimegepant + carfilzomib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • carvedilol
  • Nurtec ODT (rimegepant)
    +
    carvedilol
    1 interaction

    Monitor/Modify Tx

    rimegepant + carvedilol

    monitor BP; consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (P-gp-mediated transport inhibited; antagonistic effects)

  • celecoxib
  • Nurtec ODT (rimegepant)
    +
    celecoxib
    1 interaction

    Monitor/Modify Tx

    rimegepant + celecoxib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • chlorothiazide
  • Nurtec ODT (rimegepant)
    +
    chlorothiazide
    1 interaction

    Monitor/Modify Tx

    rimegepant + chlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • chlorthalidone
  • Nurtec ODT (rimegepant)
    +
    chlorthalidone
    1 interaction

    Monitor/Modify Tx

    rimegepant + chlorthalidone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ciprofloxacin
  • Nurtec ODT (rimegepant)
    +
    ciprofloxacin
    1 interaction

    Monitor/Modify Tx

    rimegepant + ciprofloxacin

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • clevidipine
  • Nurtec ODT (rimegepant)
    +
    clevidipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + clevidipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • clofazimine
  • Nurtec ODT (rimegepant)
    +
    clofazimine
    1 interaction

    Monitor/Modify Tx

    rimegepant + clofazimine

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • clonidine
  • Nurtec ODT (rimegepant)
    +
    clonidine
    1 interaction

    Monitor/Modify Tx

    rimegepant + clonidine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • cocaine
  • Nurtec ODT (rimegepant)
    +
    cocaine
    1 interaction

    Monitor/Modify Tx

    rimegepant + cocaine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • conivaptan
  • Nurtec ODT (rimegepant)
    +
    conivaptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + conivaptan

    separate rimegepant doses by at least 48h during and x7 days after conivaptan tx: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • copanlisib
  • Nurtec ODT (rimegepant)
    +
    copanlisib
    1 interaction

    Monitor/Modify Tx

    rimegepant + copanlisib

    monitor BP: combo may incr. risk of HTN (additive effects, copanlisib may cause infusion-related HTN)

  • corticotropin
  • Nurtec ODT (rimegepant)
    +
    corticotropin
    1 interaction

    Monitor/Modify Tx

    rimegepant + corticotropin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • cortisone
  • Nurtec ODT (rimegepant)
    +
    cortisone
    1 interaction

    Monitor/Modify Tx

    rimegepant + cortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • crizotinib
  • Nurtec ODT (rimegepant)
    +
    crizotinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + crizotinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • cyclosporine
  • Nurtec ODT (rimegepant)
    +
    cyclosporine
    1 interaction

    Monitor/Modify Tx

    rimegepant + cyclosporine

    monitor BP; separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of HTN, other adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited, additive effects)

  • danazol
  • Nurtec ODT (rimegepant)
    +
    danazol
    1 interaction

    Monitor/Modify Tx

    rimegepant + danazol

    monitor BP; separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of HTN, other adverse effects (hepatic metabolism inhibited, additive effects)

  • danicopan
  • Nurtec ODT (rimegepant)
    +
    danicopan
    1 interaction

    Monitor/Modify Tx

    rimegepant + danicopan

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • darbepoetin alfa
  • Nurtec ODT (rimegepant)
    +
    darbepoetin alfa
    1 interaction

    Monitor/Modify Tx

    rimegepant + darbepoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • darunavir
  • Nurtec ODT (rimegepant)
    +
    darunavir
    1 interaction

    Monitor/Modify Tx

    rimegepant + darunavir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • deflazacort
  • Nurtec ODT (rimegepant)
    +
    deflazacort
    1 interaction

    Monitor/Modify Tx

    rimegepant + deflazacort

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desmopressin
  • Nurtec ODT (rimegepant)
    +
    desmopressin
    1 interaction

    Monitor/Modify Tx

    rimegepant + desmopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • desvenlafaxine
  • Nurtec ODT (rimegepant)
    +
    desvenlafaxine
    1 interaction

    Monitor/Modify Tx

    rimegepant + desvenlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexamethasone
  • Nurtec ODT (rimegepant)
    +
    dexamethasone
    1 interaction

    Monitor/Modify Tx

    rimegepant + dexamethasone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dexmethylphenidate
  • Nurtec ODT (rimegepant)
    +
    dexmethylphenidate
    1 interaction

    Monitor/Modify Tx

    rimegepant + dexmethylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dextroamphetamine
  • Nurtec ODT (rimegepant)
    +
    dextroamphetamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + dextroamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac
  • Nurtec ODT (rimegepant)
    +
    diclofenac
    1 interaction

    Monitor/Modify Tx

    rimegepant + diclofenac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diclofenac topical
  • Nurtec ODT (rimegepant)
    +
    diclofenac topical
    1 interaction

    Monitor/Modify Tx

    rimegepant + diclofenac topical

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diethylpropion
  • Nurtec ODT (rimegepant)
    +
    diethylpropion
    1 interaction

    Monitor/Modify Tx

    rimegepant + diethylpropion

    monitor BP: combo may incr. risk of HTN (additive effects)

  • diflunisal
  • Nurtec ODT (rimegepant)
    +
    diflunisal
    1 interaction

    Monitor/Modify Tx

    rimegepant + diflunisal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dihydroergotamine
  • Nurtec ODT (rimegepant)
    +
    dihydroergotamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + dihydroergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • diltiazem
  • Nurtec ODT (rimegepant)
    +
    diltiazem
    1 interaction

    Monitor/Modify Tx

    rimegepant + diltiazem

    monitor BP; separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited; antagonistic effects)

  • diosmin
  • Nurtec ODT (rimegepant)
    +
    diosmin
    1 interaction

    Monitor/Modify Tx

    rimegepant + diosmin

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • dobutamine
  • Nurtec ODT (rimegepant)
    +
    dobutamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + dobutamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dopamine
  • Nurtec ODT (rimegepant)
    +
    dopamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + dopamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxapram
  • Nurtec ODT (rimegepant)
    +
    doxapram
    1 interaction

    Monitor/Modify Tx

    rimegepant + doxapram

    monitor BP: combo may incr. risk of HTN (additive effects)

  • doxazosin
  • Nurtec ODT (rimegepant)
    +
    doxazosin
    1 interaction

    Monitor/Modify Tx

    rimegepant + doxazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • dronabinol
  • Nurtec ODT (rimegepant)
    +
    dronabinol
    1 interaction

    Monitor/Modify Tx

    rimegepant + dronabinol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • dronedarone
  • Nurtec ODT (rimegepant)
    +
    dronedarone
    1 interaction

    Monitor/Modify Tx

    rimegepant + dronedarone

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • droxidopa
  • Nurtec ODT (rimegepant)
    +
    droxidopa
    1 interaction

    Monitor/Modify Tx

    rimegepant + droxidopa

    monitor BP: combo may incr. risk of supine HTN (additive effects)

  • duvelisib
  • Nurtec ODT (rimegepant)
    +
    duvelisib
    1 interaction

    Monitor/Modify Tx

    rimegepant + duvelisib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • eletriptan
  • Nurtec ODT (rimegepant)
    +
    eletriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + eletriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • enalapril
  • Nurtec ODT (rimegepant)
    +
    enalapril
    1 interaction

    Monitor/Modify Tx

    rimegepant + enalapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • enalaprilat
  • Nurtec ODT (rimegepant)
    +
    enalaprilat
    1 interaction

    Monitor/Modify Tx

    rimegepant + enalaprilat

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ephedra
  • Nurtec ODT (rimegepant)
    +
    ephedra
    1 interaction

    Monitor/Modify Tx

    rimegepant + ephedra

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine injection
  • Nurtec ODT (rimegepant)
    +
    ephedrine injection
    1 interaction

    Monitor/Modify Tx

    rimegepant + ephedrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ephedrine oral
  • Nurtec ODT (rimegepant)
    +
    ephedrine oral
    1 interaction

    Monitor/Modify Tx

    rimegepant + ephedrine oral

    monitor BP: combo may incr. risk of HTN (additive effects)

  • epinephrine
  • Nurtec ODT (rimegepant)
    +
    epinephrine
    1 interaction

    Monitor/Modify Tx

    rimegepant + epinephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • eplerenone
  • Nurtec ODT (rimegepant)
    +
    eplerenone
    1 interaction

    Monitor/Modify Tx

    rimegepant + eplerenone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • epoetin alfa
  • Nurtec ODT (rimegepant)
    +
    epoetin alfa
    1 interaction

    Monitor/Modify Tx

    rimegepant + epoetin alfa

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ergotamine
  • Nurtec ODT (rimegepant)
    +
    ergotamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + ergotamine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • erythromycin
  • Nurtec ODT (rimegepant)
    +
    erythromycin
    1 interaction

    Monitor/Modify Tx

    rimegepant + erythromycin

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • esketamine
  • Nurtec ODT (rimegepant)
    +
    esketamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + esketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • esmolol
  • Nurtec ODT (rimegepant)
    +
    esmolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + esmolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • estetrol (contraceptive)
  • Nurtec ODT (rimegepant)
    +
    estetrol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    rimegepant + estetrol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • estradiol (contraceptive)
  • Nurtec ODT (rimegepant)
    +
    estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    rimegepant + estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ethacrynic acid
  • Nurtec ODT (rimegepant)
    +
    ethacrynic acid
    1 interaction

    Monitor/Modify Tx

    rimegepant + ethacrynic acid

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ethanol (alcoholic beverage)
  • Nurtec ODT (rimegepant)
    +
    ethanol (alcoholic beverage)
    1 interaction

    Monitor/Modify Tx

    rimegepant + ethanol (alcoholic beverage)

    monitor BP: combo may incr. risk of HTN (chronic alcohol use) (additive effects)

  • ethinyl estradiol (contraceptive)
  • Nurtec ODT (rimegepant)
    +
    ethinyl estradiol (contraceptive)
    1 interaction

    Monitor/Modify Tx

    rimegepant + ethinyl estradiol (contraceptive)

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etodolac
  • Nurtec ODT (rimegepant)
    +
    etodolac
    1 interaction

    Monitor/Modify Tx

    rimegepant + etodolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • etrasimod
  • Nurtec ODT (rimegepant)
    +
    etrasimod
    1 interaction

    Monitor/Modify Tx

    rimegepant + etrasimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fedratinib
  • Nurtec ODT (rimegepant)
    +
    fedratinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + fedratinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • felodipine
  • Nurtec ODT (rimegepant)
    +
    felodipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + felodipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenfluramine
  • Nurtec ODT (rimegepant)
    +
    fenfluramine
    1 interaction

    Monitor/Modify Tx

    rimegepant + fenfluramine

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • fenoldopam
  • Nurtec ODT (rimegepant)
    +
    fenoldopam
    1 interaction

    Monitor/Modify Tx

    rimegepant + fenoldopam

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fenoprofen
  • Nurtec ODT (rimegepant)
    +
    fenoprofen
    1 interaction

    Monitor/Modify Tx

    rimegepant + fenoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fingolimod
  • Nurtec ODT (rimegepant)
    +
    fingolimod
    1 interaction

    Monitor/Modify Tx

    rimegepant + fingolimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flibanserin
  • Nurtec ODT (rimegepant)
    +
    flibanserin
    1 interaction

    Monitor/Modify Tx

    rimegepant + flibanserin

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • fluconazole
  • Nurtec ODT (rimegepant)
    +
    fluconazole
    1 interaction

    Monitor/Modify Tx

    rimegepant + fluconazole

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • fludrocortisone
  • Nurtec ODT (rimegepant)
    +
    fludrocortisone
    1 interaction

    Monitor/Modify Tx

    rimegepant + fludrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • flurbiprofen
  • Nurtec ODT (rimegepant)
    +
    flurbiprofen
    1 interaction

    Monitor/Modify Tx

    rimegepant + flurbiprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • formoterol inhaled
  • Nurtec ODT (rimegepant)
    +
    formoterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + formoterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fosamprenavir
  • Nurtec ODT (rimegepant)
    +
    fosamprenavir
    1 interaction

    Monitor/Modify Tx

    rimegepant + fosamprenavir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • fosinopril
  • Nurtec ODT (rimegepant)
    +
    fosinopril
    1 interaction

    Monitor/Modify Tx

    rimegepant + fosinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • fostamatinib
  • Nurtec ODT (rimegepant)
    +
    fostamatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + fostamatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • frovatriptan
  • Nurtec ODT (rimegepant)
    +
    frovatriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + frovatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • fruquintinib
  • Nurtec ODT (rimegepant)
    +
    fruquintinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + fruquintinib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • glecaprevir
  • Nurtec ODT (rimegepant)
    +
    glecaprevir
    1 interaction

    Monitor/Modify Tx

    rimegepant + glecaprevir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited, P-gp-mediated transport inhibited)

  • grapefruit
  • Nurtec ODT (rimegepant)
    +
    grapefruit
    1 interaction

    Monitor/Modify Tx

    rimegepant + grapefruit

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (GI metabolism inhibited)

  • guanfacine
  • Nurtec ODT (rimegepant)
    +
    guanfacine
    1 interaction

    Monitor/Modify Tx

    rimegepant + guanfacine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hoodia
  • Nurtec ODT (rimegepant)
    +
    hoodia
    1 interaction

    Monitor/Modify Tx

    rimegepant + hoodia

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydralazine
  • Nurtec ODT (rimegepant)
    +
    hydralazine
    1 interaction

    Monitor/Modify Tx

    rimegepant + hydralazine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrochlorothiazide
  • Nurtec ODT (rimegepant)
    +
    hydrochlorothiazide
    1 interaction

    Monitor/Modify Tx

    rimegepant + hydrochlorothiazide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • hydrocortisone
  • Nurtec ODT (rimegepant)
    +
    hydrocortisone
    1 interaction

    Monitor/Modify Tx

    rimegepant + hydrocortisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • hydroxocobalamin IV
  • Nurtec ODT (rimegepant)
    +
    hydroxocobalamin IV
    1 interaction

    Monitor/Modify Tx

    rimegepant + hydroxocobalamin IV

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibrutinib
  • Nurtec ODT (rimegepant)
    +
    ibrutinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + ibrutinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ibuprofen
  • Nurtec ODT (rimegepant)
    +
    ibuprofen
    1 interaction

    Monitor/Modify Tx

    rimegepant + ibuprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • imatinib
  • Nurtec ODT (rimegepant)
    +
    imatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + imatinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • indapamide
  • Nurtec ODT (rimegepant)
    +
    indapamide
    1 interaction

    Monitor/Modify Tx

    rimegepant + indapamide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • indomethacin
  • Nurtec ODT (rimegepant)
    +
    indomethacin
    1 interaction

    Monitor/Modify Tx

    rimegepant + indomethacin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • irbesartan
  • Nurtec ODT (rimegepant)
    +
    irbesartan
    1 interaction

    Monitor/Modify Tx

    rimegepant + irbesartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • isavuconazonium
  • Nurtec ODT (rimegepant)
    +
    isavuconazonium
    1 interaction

    Monitor/Modify Tx

    rimegepant + isavuconazonium

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • isradipine
  • Nurtec ODT (rimegepant)
    +
    isradipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + isradipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ketamine
  • Nurtec ODT (rimegepant)
    +
    ketamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + ketamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketoprofen
  • Nurtec ODT (rimegepant)
    +
    ketoprofen
    1 interaction

    Monitor/Modify Tx

    rimegepant + ketoprofen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ketorolac
  • Nurtec ODT (rimegepant)
    +
    ketorolac
    1 interaction

    Monitor/Modify Tx

    rimegepant + ketorolac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • labetalol
  • Nurtec ODT (rimegepant)
    +
    labetalol
    1 interaction

    Monitor/Modify Tx

    rimegepant + labetalol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • lanreotide
  • Nurtec ODT (rimegepant)
    +
    lanreotide
    1 interaction

    Monitor/Modify Tx

    rimegepant + lanreotide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lapatinib
  • Nurtec ODT (rimegepant)
    +
    lapatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + lapatinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • ledipasvir
  • Nurtec ODT (rimegepant)
    +
    ledipasvir
    1 interaction

    Monitor/Modify Tx

    rimegepant + ledipasvir

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (gut P-gp-mediated transport inhibited)

  • lefamulin
  • Nurtec ODT (rimegepant)
    +
    lefamulin
    1 interaction

    Monitor/Modify Tx

    rimegepant + lefamulin

    ORAL LEFAMULIN: separate rimegepant doses by at least 48h; IV lefamulin use OK: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • leflunomide
  • Nurtec ODT (rimegepant)
    +
    leflunomide
    1 interaction

    Monitor/Modify Tx

    rimegepant + leflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lenacapavir
  • Nurtec ODT (rimegepant)
    +
    lenacapavir
    1 interaction

    Monitor/Modify Tx

    rimegepant + lenacapavir

    separate rimegepant doses by at least 48h during and x9mo after lenacapavir tx: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • lenvatinib
  • Nurtec ODT (rimegepant)
    +
    lenvatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + lenvatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • letermovir
  • Nurtec ODT (rimegepant)
    +
    letermovir
    1 interaction

    Monitor/Modify Tx

    rimegepant + letermovir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • levalbuterol inhaled
  • Nurtec ODT (rimegepant)
    +
    levalbuterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + levalbuterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • levomilnacipran
  • Nurtec ODT (rimegepant)
    +
    levomilnacipran
    1 interaction

    Monitor/Modify Tx

    rimegepant + levomilnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • licorice
  • Nurtec ODT (rimegepant)
    +
    licorice
    1 interaction

    Monitor/Modify Tx

    rimegepant + licorice

    monitor BP w/ large amounts of licorice: combo may incr. risk of HTN (additive effects)

  • lisdexamfetamine
  • Nurtec ODT (rimegepant)
    +
    lisdexamfetamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + lisdexamfetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • lisinopril
  • Nurtec ODT (rimegepant)
    +
    lisinopril
    1 interaction

    Monitor/Modify Tx

    rimegepant + lisinopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • losartan
  • Nurtec ODT (rimegepant)
    +
    losartan
    1 interaction

    Monitor/Modify Tx

    rimegepant + losartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • luspatercept
  • Nurtec ODT (rimegepant)
    +
    luspatercept
    1 interaction

    Monitor/Modify Tx

    rimegepant + luspatercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • magnesium salicylate
  • Nurtec ODT (rimegepant)
    +
    magnesium salicylate
    1 interaction

    Monitor/Modify Tx

    rimegepant + magnesium salicylate

    monitor BP w/ high-dose magnesium salicylate: combo may incr. risk of HTN (additive effects)

  • mavorixafor
  • Nurtec ODT (rimegepant)
    +
    mavorixafor
    1 interaction

    Monitor/Modify Tx

    rimegepant + mavorixafor

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • meclofenamate
  • Nurtec ODT (rimegepant)
    +
    meclofenamate
    1 interaction

    Monitor/Modify Tx

    rimegepant + meclofenamate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • mefenamic acid
  • Nurtec ODT (rimegepant)
    +
    mefenamic acid
    1 interaction

    Monitor/Modify Tx

    rimegepant + mefenamic acid

    monitor BP: combo may incr. risk of HTN (additive effects)

  • meloxicam
  • Nurtec ODT (rimegepant)
    +
    meloxicam
    1 interaction

    Monitor/Modify Tx

    rimegepant + meloxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methamphetamine
  • Nurtec ODT (rimegepant)
    +
    methamphetamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + methamphetamine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methoxy polyethylene glycol-epoetin beta
  • Nurtec ODT (rimegepant)
    +
    methoxy polyethylene glycol-epoetin beta
    1 interaction

    Monitor/Modify Tx

    rimegepant + methoxy polyethylene glycol-epoetin beta

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyldopa
  • Nurtec ODT (rimegepant)
    +
    methyldopa
    1 interaction

    Monitor/Modify Tx

    rimegepant + methyldopa

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • methylergonovine
  • Nurtec ODT (rimegepant)
    +
    methylergonovine
    1 interaction

    Monitor/Modify Tx

    rimegepant + methylergonovine

    monitor BP: combo may incr. risk of severe HTN, vasospasm, ischemia (additive effects)

  • methylphenidate
  • Nurtec ODT (rimegepant)
    +
    methylphenidate
    1 interaction

    Monitor/Modify Tx

    rimegepant + methylphenidate

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methylprednisolone
  • Nurtec ODT (rimegepant)
    +
    methylprednisolone
    1 interaction

    Monitor/Modify Tx

    rimegepant + methylprednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • methyltestosterone
  • Nurtec ODT (rimegepant)
    +
    methyltestosterone
    1 interaction

    Monitor/Modify Tx

    rimegepant + methyltestosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metoclopramide
  • Nurtec ODT (rimegepant)
    +
    metoclopramide
    1 interaction

    Monitor/Modify Tx

    rimegepant + metoclopramide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • metolazone
  • Nurtec ODT (rimegepant)
    +
    metolazone
    1 interaction

    Monitor/Modify Tx

    rimegepant + metolazone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • metoprolol
  • Nurtec ODT (rimegepant)
    +
    metoprolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + metoprolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • milnacipran
  • Nurtec ODT (rimegepant)
    +
    milnacipran
    1 interaction

    Monitor/Modify Tx

    rimegepant + milnacipran

    monitor BP: combo may incr. risk of HTN (additive effects)

  • minoxidil
  • Nurtec ODT (rimegepant)
    +
    minoxidil
    1 interaction

    Monitor/Modify Tx

    rimegepant + minoxidil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • mirabegron
  • Nurtec ODT (rimegepant)
    +
    mirabegron
    1 interaction

    Monitor/Modify Tx

    rimegepant + mirabegron

    monitor BP: combo may incr. risk of HTN (additive effects)

  • moexipril
  • Nurtec ODT (rimegepant)
    +
    moexipril
    1 interaction

    Monitor/Modify Tx

    rimegepant + moexipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nabumetone
  • Nurtec ODT (rimegepant)
    +
    nabumetone
    1 interaction

    Monitor/Modify Tx

    rimegepant + nabumetone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nadolol
  • Nurtec ODT (rimegepant)
    +
    nadolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + nadolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • naproxen
  • Nurtec ODT (rimegepant)
    +
    naproxen
    1 interaction

    Monitor/Modify Tx

    rimegepant + naproxen

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naratriptan
  • Nurtec ODT (rimegepant)
    +
    naratriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + naratriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • naxitamab
  • Nurtec ODT (rimegepant)
    +
    naxitamab
    1 interaction

    Monitor/Modify Tx

    rimegepant + naxitamab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nebivolol
  • Nurtec ODT (rimegepant)
    +
    nebivolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + nebivolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nicardipine
  • Nurtec ODT (rimegepant)
    +
    nicardipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + nicardipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nifedipine
  • Nurtec ODT (rimegepant)
    +
    nifedipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + nifedipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • nilotinib
  • Nurtec ODT (rimegepant)
    +
    nilotinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + nilotinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • nimodipine
  • Nurtec ODT (rimegepant)
    +
    nimodipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + nimodipine

    monitor BP: combo may decr. nimodipine efficacy (antagonistic effects)

  • niraparib
  • Nurtec ODT (rimegepant)
    +
    niraparib
    1 interaction

    Monitor/Modify Tx

    rimegepant + niraparib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • nirogacestat
  • Nurtec ODT (rimegepant)
    +
    nirogacestat
    1 interaction

    Monitor/Modify Tx

    rimegepant + nirogacestat

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • nisoldipine
  • Nurtec ODT (rimegepant)
    +
    nisoldipine
    1 interaction

    Monitor/Modify Tx

    rimegepant + nisoldipine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • norepinephrine
  • Nurtec ODT (rimegepant)
    +
    norepinephrine
    1 interaction

    Monitor/Modify Tx

    rimegepant + norepinephrine

    monitor BP: combo may incr. risk of severe HTN (additive effects)

  • obinutuzumab
  • Nurtec ODT (rimegepant)
    +
    obinutuzumab
    1 interaction

    Monitor/Modify Tx

    rimegepant + obinutuzumab

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • olmesartan medoxomil
  • Nurtec ODT (rimegepant)
    +
    olmesartan medoxomil
    1 interaction

    Monitor/Modify Tx

    rimegepant + olmesartan medoxomil

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • olodaterol inhaled
  • Nurtec ODT (rimegepant)
    +
    olodaterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + olodaterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • osilodrostat
  • Nurtec ODT (rimegepant)
    +
    osilodrostat
    1 interaction

    Monitor/Modify Tx

    rimegepant + osilodrostat

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxaprozin
  • Nurtec ODT (rimegepant)
    +
    oxaprozin
    1 interaction

    Monitor/Modify Tx

    rimegepant + oxaprozin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxymetazoline nasal
  • Nurtec ODT (rimegepant)
    +
    oxymetazoline nasal
    1 interaction

    Monitor/Modify Tx

    rimegepant + oxymetazoline nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • oxytocin
  • Nurtec ODT (rimegepant)
    +
    oxytocin
    1 interaction

    Monitor/Modify Tx

    rimegepant + oxytocin

    monitor BP: combo may incr. risk of HTN, including life-threatening (additive effects)

  • ozanimod
  • Nurtec ODT (rimegepant)
    +
    ozanimod
    1 interaction

    Monitor/Modify Tx

    rimegepant + ozanimod

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • pazopanib
  • Nurtec ODT (rimegepant)
    +
    pazopanib
    1 interaction

    Monitor/Modify Tx

    rimegepant + pazopanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • perindopril
  • Nurtec ODT (rimegepant)
    +
    perindopril
    1 interaction

    Monitor/Modify Tx

    rimegepant + perindopril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phendimetrazine
  • Nurtec ODT (rimegepant)
    +
    phendimetrazine
    1 interaction

    Monitor/Modify Tx

    rimegepant + phendimetrazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenoxybenzamine
  • Nurtec ODT (rimegepant)
    +
    phenoxybenzamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenoxybenzamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phentermine
  • Nurtec ODT (rimegepant)
    +
    phentermine
    1 interaction

    Monitor/Modify Tx

    rimegepant + phentermine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phentolamine
  • Nurtec ODT (rimegepant)
    +
    phentolamine
    1 interaction

    Monitor/Modify Tx

    rimegepant + phentolamine

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • phenylephrine
  • Nurtec ODT (rimegepant)
    +
    phenylephrine
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenylephrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine injection
  • Nurtec ODT (rimegepant)
    +
    phenylephrine injection
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenylephrine injection

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine nasal
  • Nurtec ODT (rimegepant)
    +
    phenylephrine nasal
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenylephrine nasal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • phenylephrine ophthalmic
  • Nurtec ODT (rimegepant)
    +
    phenylephrine ophthalmic
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenylephrine ophthalmic

    monitor BP; HTN risk may be lower w/ phenylephrine ophthalmic 2.5%: combo may incr. risk of HTN (additive effects)

  • phenylephrine rectal
  • Nurtec ODT (rimegepant)
    +
    phenylephrine rectal
    1 interaction

    Monitor/Modify Tx

    rimegepant + phenylephrine rectal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pibrentasvir
  • Nurtec ODT (rimegepant)
    +
    pibrentasvir
    1 interaction

    Monitor/Modify Tx

    rimegepant + pibrentasvir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • pindolol
  • Nurtec ODT (rimegepant)
    +
    pindolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + pindolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • piroxicam
  • Nurtec ODT (rimegepant)
    +
    piroxicam
    1 interaction

    Monitor/Modify Tx

    rimegepant + piroxicam

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponatinib
  • Nurtec ODT (rimegepant)
    +
    ponatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + ponatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ponesimod
  • Nurtec ODT (rimegepant)
    +
    ponesimod
    1 interaction

    Monitor/Modify Tx

    rimegepant + ponesimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • pralsetinib
  • Nurtec ODT (rimegepant)
    +
    pralsetinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + pralsetinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prazosin
  • Nurtec ODT (rimegepant)
    +
    prazosin
    1 interaction

    Monitor/Modify Tx

    rimegepant + prazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • prednisolone
  • Nurtec ODT (rimegepant)
    +
    prednisolone
    1 interaction

    Monitor/Modify Tx

    rimegepant + prednisolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • prednisone
  • Nurtec ODT (rimegepant)
    +
    prednisone
    1 interaction

    Monitor/Modify Tx

    rimegepant + prednisone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • propafenone
  • Nurtec ODT (rimegepant)
    +
    propafenone
    1 interaction

    Monitor/Modify Tx

    rimegepant + propafenone

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • propranolol
  • Nurtec ODT (rimegepant)
    +
    propranolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + propranolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • pseudoephedrine
  • Nurtec ODT (rimegepant)
    +
    pseudoephedrine
    1 interaction

    Monitor/Modify Tx

    rimegepant + pseudoephedrine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • quetiapine
  • Nurtec ODT (rimegepant)
    +
    quetiapine
    1 interaction

    Monitor/Modify Tx

    rimegepant + quetiapine

    monitor BP, especially in pts <18 yo: combo may incr. risk of HTN (additive effects)

  • quinapril
  • Nurtec ODT (rimegepant)
    +
    quinapril
    1 interaction

    Monitor/Modify Tx

    rimegepant + quinapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • quinidine (antiarrhythmic)
  • Nurtec ODT (rimegepant)
    +
    quinidine (antiarrhythmic)
    1 interaction

    Monitor/Modify Tx

    rimegepant + quinidine (antiarrhythmic)

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • ramipril
  • Nurtec ODT (rimegepant)
    +
    ramipril
    1 interaction

    Monitor/Modify Tx

    rimegepant + ramipril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • ramucirumab
  • Nurtec ODT (rimegepant)
    +
    ramucirumab
    1 interaction

    Monitor/Modify Tx

    rimegepant + ramucirumab

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ranolazine
  • Nurtec ODT (rimegepant)
    +
    ranolazine
    1 interaction

    Monitor/Modify Tx

    rimegepant + ranolazine

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • regorafenib
  • Nurtec ODT (rimegepant)
    +
    regorafenib
    1 interaction

    Monitor/Modify Tx

    rimegepant + regorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rilzabrutinib
  • Nurtec ODT (rimegepant)
    +
    rilzabrutinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + rilzabrutinib

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (hepatic metabolism inhibited)

  • ripretinib
  • Nurtec ODT (rimegepant)
    +
    ripretinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + ripretinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rizatriptan
  • Nurtec ODT (rimegepant)
    +
    rizatriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + rizatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ropinirole
  • Nurtec ODT (rimegepant)
    +
    ropinirole
    1 interaction

    Monitor/Modify Tx

    rimegepant + ropinirole

    monitor BP: combo may incr. risk of HTN (additive effects)

  • rotigotine transdermal
  • Nurtec ODT (rimegepant)
    +
    rotigotine transdermal
    1 interaction

    Monitor/Modify Tx

    rimegepant + rotigotine transdermal

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salmeterol inhaled
  • Nurtec ODT (rimegepant)
    +
    salmeterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + salmeterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • salsalate
  • Nurtec ODT (rimegepant)
    +
    salsalate
    1 interaction

    Monitor/Modify Tx

    rimegepant + salsalate

    monitor BP w/ high-dose salsalate: combo may incr. risk of HTN (additive effects)

  • selpercatinib
  • Nurtec ODT (rimegepant)
    +
    selpercatinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + selpercatinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • siponimod
  • Nurtec ODT (rimegepant)
    +
    siponimod
    1 interaction

    Monitor/Modify Tx

    rimegepant + siponimod

    monitor BP: combo may incr. risk of HTN (additive effects)

  • solriamfetol
  • Nurtec ODT (rimegepant)
    +
    solriamfetol
    1 interaction

    Monitor/Modify Tx

    rimegepant + solriamfetol

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sorafenib
  • Nurtec ODT (rimegepant)
    +
    sorafenib
    1 interaction

    Monitor/Modify Tx

    rimegepant + sorafenib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • spironolactone
  • Nurtec ODT (rimegepant)
    +
    spironolactone
    1 interaction

    Monitor/Modify Tx

    rimegepant + spironolactone

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • sulindac
  • Nurtec ODT (rimegepant)
    +
    sulindac
    1 interaction

    Monitor/Modify Tx

    rimegepant + sulindac

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sumatriptan
  • Nurtec ODT (rimegepant)
    +
    sumatriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + sumatriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

  • sunitinib
  • Nurtec ODT (rimegepant)
    +
    sunitinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + sunitinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tacrolimus
  • Nurtec ODT (rimegepant)
    +
    tacrolimus
    1 interaction

    Monitor/Modify Tx

    rimegepant + tacrolimus

    monitor BP: combo may incr. risk of HTN (additive effects)

  • tagraxofusp
  • Nurtec ODT (rimegepant)
    +
    tagraxofusp
    1 interaction

    Monitor/Modify Tx

    rimegepant + tagraxofusp

    monitor BP: combo may incr. risk of HTN (additive effects)

  • telmisartan
  • Nurtec ODT (rimegepant)
    +
    telmisartan
    1 interaction

    Monitor/Modify Tx

    rimegepant + telmisartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tepotinib
  • Nurtec ODT (rimegepant)
    +
    tepotinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + tepotinib

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • terazosin
  • Nurtec ODT (rimegepant)
    +
    terazosin
    1 interaction

    Monitor/Modify Tx

    rimegepant + terazosin

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • terbutaline
  • Nurtec ODT (rimegepant)
    +
    terbutaline
    1 interaction

    Monitor/Modify Tx

    rimegepant + terbutaline

    monitor BP: combo may incr. risk of HTN (additive effects)

  • teriflunomide
  • Nurtec ODT (rimegepant)
    +
    teriflunomide
    1 interaction

    Monitor/Modify Tx

    rimegepant + teriflunomide

    monitor BP: combo may incr. risk of HTN (additive effects)

  • testosterone
  • Nurtec ODT (rimegepant)
    +
    testosterone
    1 interaction

    Monitor/Modify Tx

    rimegepant + testosterone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • timolol
  • Nurtec ODT (rimegepant)
    +
    timolol
    1 interaction

    Monitor/Modify Tx

    rimegepant + timolol

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • tivozanib
  • Nurtec ODT (rimegepant)
    +
    tivozanib
    1 interaction

    Monitor/Modify Tx

    rimegepant + tivozanib

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • tolmetin
  • Nurtec ODT (rimegepant)
    +
    tolmetin
    1 interaction

    Monitor/Modify Tx

    rimegepant + tolmetin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • torsemide
  • Nurtec ODT (rimegepant)
    +
    torsemide
    1 interaction

    Monitor/Modify Tx

    rimegepant + torsemide

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • trametinib
  • Nurtec ODT (rimegepant)
    +
    trametinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + trametinib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • trandolapril
  • Nurtec ODT (rimegepant)
    +
    trandolapril
    1 interaction

    Monitor/Modify Tx

    rimegepant + trandolapril

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • triamcinolone
  • Nurtec ODT (rimegepant)
    +
    triamcinolone
    1 interaction

    Monitor/Modify Tx

    rimegepant + triamcinolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • triamterene
  • Nurtec ODT (rimegepant)
    +
    triamterene
    1 interaction

    Monitor/Modify Tx

    rimegepant + triamterene

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • turmeric
  • Nurtec ODT (rimegepant)
    +
    turmeric
    1 interaction

    Monitor/Modify Tx

    rimegepant + turmeric

    separate rimegepant doses by at least 48h w/ oral turmeric: combo may incr. rimegepant levels, risk of adverse effects (gut P-gp-mediated transport inhibited)

  • vadadustat
  • Nurtec ODT (rimegepant)
    +
    vadadustat
    1 interaction

    Monitor/Modify Tx

    rimegepant + vadadustat

    monitor BP: combo may incr. risk of HTN, including hypertensive crisis (additive effects)

  • valsartan
  • Nurtec ODT (rimegepant)
    +
    valsartan
    1 interaction

    Monitor/Modify Tx

    rimegepant + valsartan

    monitor BP: combo may decr. antihypertensive agent efficacy (antagonistic effects)

  • vamorolone
  • Nurtec ODT (rimegepant)
    +
    vamorolone
    1 interaction

    Monitor/Modify Tx

    rimegepant + vamorolone

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vandetanib
  • Nurtec ODT (rimegepant)
    +
    vandetanib
    1 interaction

    Monitor/Modify Tx

    rimegepant + vandetanib

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vasopressin
  • Nurtec ODT (rimegepant)
    +
    vasopressin
    1 interaction

    Monitor/Modify Tx

    rimegepant + vasopressin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vemurafenib
  • Nurtec ODT (rimegepant)
    +
    vemurafenib
    1 interaction

    Monitor/Modify Tx

    rimegepant + vemurafenib

    consider separating rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • venlafaxine
  • Nurtec ODT (rimegepant)
    +
    venlafaxine
    1 interaction

    Monitor/Modify Tx

    rimegepant + venlafaxine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • verapamil
  • Nurtec ODT (rimegepant)
    +
    verapamil
    1 interaction

    Monitor/Modify Tx

    rimegepant + verapamil

    monitor BP; separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects; may decr. antihypertensive agent efficacy (hepatic metabolism inhibited, P-gp-mediated transport inhibited; antagonistic effects)

  • vilanterol inhaled
  • Nurtec ODT (rimegepant)
    +
    vilanterol inhaled
    1 interaction

    Monitor/Modify Tx

    rimegepant + vilanterol inhaled

    monitor BP: combo may incr. risk of HTN (additive effects)

  • viloxazine
  • Nurtec ODT (rimegepant)
    +
    viloxazine
    1 interaction

    Monitor/Modify Tx

    rimegepant + viloxazine

    monitor BP: combo may incr. risk of HTN (additive effects)

  • vimseltinib
  • Nurtec ODT (rimegepant)
    +
    vimseltinib
    1 interaction

    Monitor/Modify Tx

    rimegepant + vimseltinib

    separate rimegepant doses by at least 48h; give vimseltinib at least 4h before rimegepant: combo may incr. rimegepant levels, risk of adverse effects (P-gp-mediated transport inhibited)

  • voclosporin
  • Nurtec ODT (rimegepant)
    +
    voclosporin
    1 interaction

    Monitor/Modify Tx

    rimegepant + voclosporin

    monitor BP: combo may incr. risk of HTN (additive effects)

  • voxilaprevir
  • Nurtec ODT (rimegepant)
    +
    voxilaprevir
    1 interaction

    Monitor/Modify Tx

    rimegepant + voxilaprevir

    separate rimegepant doses by at least 48h: combo may incr. rimegepant levels, risk of adverse effects (gut P-gp-mediated transport inhibited)

  • yohimbe
  • Nurtec ODT (rimegepant)
    +
    yohimbe
    1 interaction

    Monitor/Modify Tx

    rimegepant + yohimbe

    monitor BP: combo may incr. risk of HTN (additive effects)

  • ziv-aflibercept
  • Nurtec ODT (rimegepant)
    +
    ziv-aflibercept
    1 interaction

    Monitor/Modify Tx

    rimegepant + ziv-aflibercept

    monitor BP: combo may incr. risk of HTN (additive effects)

  • zolmitriptan
  • Nurtec ODT (rimegepant)
    +
    zolmitriptan
    1 interaction

    Monitor/Modify Tx

    rimegepant + zolmitriptan

    monitor BP: combo may incr. risk of HTN (additive effects)

Adverse Reactions .

Serious Reactions

    com.epocrates.rxweb.beans.StringCollection@78cbd507
  • hypersensitivity reaction, immediate or delayed
  • anaphylaxis
  • dyspnea
  • rash, severe
  • HTN
  • Raynaud phenomenon

Common Reactions

    com.epocrates.rxweb.beans.StringCollection@2a96ce8c
  • nausea
  • abdominal pain
  • dyspepsia

Safety/Monitoring .

Monitoring Parameters
BP

Pregnancy/Lactation .

Pregnancy

Clinical Summary

weigh risk/benefit during pregnancy; no human data available; no known risk of fetal harm based on animal data at up to 45x MRHD

Pregnancy Registry

enroll patients or encourage patients to enroll in Migraine Observational Nurtec Pregnancy Registry at 1-877-366-0324 or www.nurtecpregnancyregistry.com or email nurtecpregnancyregistry@ppd.com

Lactation

Clinical Summary

weigh risk/benefit while breastfeeding; inadequate human data available, though risk of infant harm not expected based on limited drug excretion into milk; no human data available to assess effects on milk production

Pharmacology .

com.epocrates.rxweb.beans.DrugOtherInfoBean@6bd8b65c

Metabolism: for rimegepant: unknown; CYP450: 2C9, 3A4 (primary) substrate

Excretion: for rimegepant: feces 78% (42% unchanged), urine 24% (51% unchanged); Half-life: 11h

Subclass: CGRP Inhibitors ; Headache/Migraine

Mechanism of Action
for rimegepant: blocks calcitonin gene-related peptide (CGRP) activity

Formulary .

No Formulary Selected

Manufacturer/Pricing .

Manufacturer: Pfizer Inc.

com.epocrates.rxweb.beans.DrugOtherInfoBean@7447f954

DEA/FDA: Rx

Retail Price

Estimated prices only. For current pricing, visit GoodRx.

oral disintegrating tablet:

  • 75 mg (1 dose pack, 8 tablets): $920.00

Join Now to View Patient Handouts!

Create a FREE epocrates Online account to access patient medication instructions. Your patients and caregivers will appreciate you printing these friendly handouts, available in English and Spanish. Each handout addresses common concerns such as how to take the medication, and possible side effects.

Current Members: Sign In.

Sign Up Now - It's Free >>

Pill Pictures

Join Now to View Pill Pictures!

Create a FREE epocrates Online account to access full-color images of medications within the drug monograph.

Current Members: Sign In.

Sign Up Now - It's Free >>

Help
FDA Reporting Form
 
Download Epocrates from the App Store Download Epocrates from the Play Store
About Us Features Business Solutions Help & Feedback
© 2026 epocrates, Inc.    Terms of Use Privacy Policy Editorial Policy Do Not Sell or Share My Information